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The Bcl-2-associated X protein (Bax) and Bcl-2-
antagonist/killer (Bak) are essential regulators
of lymphocyte apoptosis, but whether they play
a role in viable T cell function remains unclear.
Here, we report that T cells lacking both Bax
and Bak display defects in antigen-specific pro-
liferation because of Ca2+-signaling defects.
Bax/, Bak/ T cells displayed defective T cell
receptor (TCR)- and inositol-1,4,5-trisphos-
phate (IP3)-dependent Ca
2+ mobilization be-
cause of altered endoplasmic reticulum (ER)
Ca2+ regulation that was reversed byBax’s rein-
troduction. The ability of TCR-dependent Ca2+
signals to stimulate mitochondrial NADH pro-
duction in excess of that utilized for ATP syn-
thesis was dependent on Bax and Bak. Blunting
of Ca2+-induced mitochondrial NADH elevation
in the absence of Bax and Bak resulted in de-
creased reactive-oxygen-species production,
which was required for T cell proliferation. To-
gether, the data establish that Bax and Bak play
an essential role in the control of T cell prolifer-
ation by modulating ER Ca2+ release.
INTRODUCTION
Antigenic stimulation of T lymphocytes through the T cell
receptor (TCR) initiates a coordinated program of activa-
tion, proliferation, and differentiation. This program of268 Immunity 27, 268–280, August 2007 ª2007 Elsevier Inc.expansion and differentiation gives rise to a pool of
activated T cells that function to control and clear foreign
pathogens. Effective initiation of T lymphocyte activation is
critical for proper function of the adaptive immune system
(Ohashi, 2002). An equally important step in the T cell re-
sponse is the elimination of excess effector T cells and the
generationof a long-term memoryT cell pool after pathogen
clearance (Marsden and Strasser, 2003). Defects inapopto-
sis are the underlying cause of several lymphoproliferative
syndromes in mice and humans (Bidere et al., 2006), sug-
gesting that deregulated T cell survival after activation
may lead to the accumulation of excess lymphocytes and
the development of autoimmunity.
Members of the B cell leukemia/lymphoma-2 (Bcl-2)
protein family play central roles in the regulation of T cell
survival and apoptosis. Bcl-2-associated X protein (Bax)
and Bcl-2-antagonist/killer (Bak)—proapoptotic members
of this family—are required for the induction of mitochon-
drial-dependent apoptotic pathways in multiple tissue and
cell types (Lindsten et al., 2000). Either Bax or Bak is
required for cytochrome c release from mitochondria in
response to apoptotic stimuli (Wei et al., 2000; Cheng
et al., 2001), and cells lacking both Bax and Bak are resis-
tant to cell death induced by a variety of stimuli including
DNA damage, growth-factor withdrawal, and nutrient
starvation (Wei et al., 2001). Antiapoptotic members of
this family including Bcl-2 and Bcl-XL antagonize the
prodeath functions of Bax and Bak. Concurrent with this
model, transgenic overexpression of Bcl-2 or Bcl-XL in the
T cell lineage is protective (Sentman et al., 1991; Strasser
et al., 1991; Chao et al., 1995), whereas loss of these pro-
teins through genetic deletion decreases the viability of
developing and mature lymphocytes (Veis et al., 1993; Na-
kayama et al., 1994; Motoyama et al., 1995).Bax/, Bak/
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eral T cell homeostasis marked by enhanced survival of thy-
mocytes and the development of splenomegaly and lymph-
adenopathy (Lindsten et al., 2000; Rathmell et al., 2002).
Together, these data suggest that Bax and Bak are key reg-
ulators of T cell apoptosis and as such may modulate T cell
accumulation during and after an immune response.
Ca2+ is an important second messenger involved in the
control of T cell proliferation, apoptosis, differentiation,
and metabolism. One of the key signaling events triggered
by TCR engagement is the elevation of cytoplasmic Ca2+
concentration ([Ca2+]i). TCR-dependent intracellular Ca
2+
flux occurs through two distinct steps. First, inositol-
1,4,5-trisphosphate (IP3) generated after TCR ligation
promotes the release of Ca2+ from endoplasmic reticulum
(ER) stores. Depletion of ER Ca2+ stores promotes the
influx of Ca2+ from the extracellular environment through
Ca2+-release-activated Ca2+ (CRAC) channels (Venkata-
chalam et al., 2002). In addition to their role in mitochon-
drial physiology, Bcl-2 family members also function at the
ER to modulate intracellular Ca2+ homeostasis. Although
the data remain controversial, proteins of the Bcl-2 family
have been shown to affect Ca2+ homeostasis through
control of ER Ca2+ leak at least in part by modulating IP3
receptor (IP3R) activity (Chen et al., 2004; Oakes et al.,
2005; White et al., 2005). Both proapoptotic and antiapop-
totic members of the Bcl-2 family localize to the ER, and
Bcl-XL interacts directly with the IP3R to modulate its sen-
sitivity to IP3 (Zong et al., 2003; White et al., 2005). Bcl-2
has been shown to bind to the IP3R and negatively regu-
late Ca2+ flux (Chen et al., 2004). Transgenic overexpres-
sion of Bcl-2 or Bcl-XL can affect Ca
2+ mobilization in T
cells (Linette et al., 1996; Li et al., 2002). Whether Bax or
Bak plays a physiological role in the control of Ca2+ signal-
ing in T cells has not been investigated.
The central role of Bax and Bak in the control of apopto-
sis is now well established. However, whether these
molecules contribute to the normal physiology of viable
peripheral T cells remains unclear. Here, we report that
combined deficiency of Bax and Bak in lymphocytes leads
to profound defects in T cell proliferation in vitro and in
vivo. T cells deficient for both Bax and Bak displayed
decreased [Ca2+]i signaling in response to TCR stimula-
tion, and this signaling could be restored through reintro-
duction of Bax. Bax/, Bak/ T cells displayed [Ca2+]i
oscillations of higher frequency but lower amplitude in
response to TCR stimulation that resulted in an overall
lower [Ca2+]i signal relative to wild-type T cells. Restora-
tion of Ca2+ signaling through addition of ionomycin res-
cued this proliferative defect. Bax and Bak were required
for the Ca2+-dependent production of mitochondrial
NAD(P)H in response to TCR stimulation. This stimulation
of mitochondrial NAD(P)H during T cell activation is in
excess of the ability of the mitochondrial ATP synthase
to convert the NADH into ATP and contributed to a stimu-
lation of cellular reactive oxygen species (ROS) produc-
tion. Ca2+-dependent ROS production was inhibited in
DKO T cells. Consistent with recent reports, normal
T cell proliferation was blocked when TCR-dependentROS signals were inhibited, even in the presence of
elevated [Ca2+]i. Our studies demonstrate that Bax and
Bak are critical regulators of T cell proliferation through
regulation of TCR-dependent Ca2+ mobilization, mito-
chondrial bioenergetics, and ROS production.
RESULTS
Bax and Bak Are Essential for T Cell Proliferation
and Apoptosis
Mice deficient for both Bax and Bak display developmental
and homeostatic irregularities in multiple tissues including
the hematopoietic system (Lindsten et al., 2000). To study
the specific effect of combined deficiency of Bax and Bak
on peripheral T cell function, we reconstituted lethally irra-
diated recombination-activating gene-1 (RAG-1)-deficient
mice with bone marrow or fetal liver fromBax/, Bak/ or
wild-type (WT) donors. T cells were isolated from the
spleen and lymph nodes of Bax/, Bak/ or wild-type
chimeric animals and stimulated with anti-CD3. Bax/,
Bak/ T cells displayed defective proliferation in relation
to control T cells (Figure 1A). The decreased proliferative
response of Bax/, Bak/ T cells was most evident at
lower concentrations (<5 mg/ml) of anti-CD3, suggesting
that loss of Bax and Bak raises the threshold for T cell ac-
tivation. The addition of anti-CD28 enhanced but did not
correct the proliferative response ofBax/, Bak/ T cells
(Figure 1B). As observed with conventionalBax/, Bak/
mice, Bax/, Bak/ chimeric mice developed homeo-
static defects in the peripheral lymphoid organs (spleno-
megaly and lymphadenopathy) marked by an accumula-
tion of resting T cells with a memory-like phenotype
(Figure S1 in the Supplemental Data available online).
However, the resting T cells that accumulate in Bax/,
Bak/ chimeric mice displayed no substantial changes
in their T cell repertoire (Figure S2). TCR-dependent prolif-
eration of T cells from animals lacking either Bax or Bak
alone was similar to wild-type cells, suggesting that Bax
and Bak perform redundant functions with respect to
T cell proliferation (Figure S3).
Analysis of T cell division by CFSE dye dilution revealed
that CD4+ T cells from Bax/, Bak/ chimeric animals
displayed a profound delay in cell division in response to
anti-CD3 treatment, with a majority of cells being unable
to initiate cell division 3 days after activation (Figure 1C).
This decrease in cell division was accompanied by a de-
creased ability to upregulate the T cell activation markers
CD25 and CD69 in Bax/, Bak/ T cells in response to
anti-CD3 treatment, despite a slightly increased basal ex-
pression of these markers in the resting Bax/, Bak/ T
cells (Figure 1D). Normal upregulation of CD25 and CD69
could not be fully rescued by CD28 costimulation. To-
gether, these data reveal a requirement for Bax and Bak
in the control of T cell activation and proliferation in
response to antigen-receptor stimulation.
To assess whether Bax/, Bak/ T cells remain resis-
tant to apoptosis despite eliciting a defective proliferative
response, we cultured wild-type and Bax/, Bak/
T cells in cytokine-free medium after activation, and cellImmunity 27, 268–280, August 2007 ª2007 Elsevier Inc. 269
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Bax and Bak Regulate Ca2+-Dependent T Cell ProliferationFigure 1. Bax and Bak Are Required for T Cell Activation and Apoptosis
(A and B) Proliferation of peripheral T cells isolated from Rag1/ animals reconstituted with wild-type (WT, closed circles) or Bax/, Bak/ (open
circles) bone marrow. T cells were stimulated with plate-bound anti-CD3 alone (A) or in combination with 1 mg/ml anti-CD28 (B), and proliferation was
measured on day 3 postactivation. 3[H]-thymidine was added during the last 12 hr of culture. Each data point represents the mean ± SD for triplicate
cultures and is representative of four independent experiments.
(C) CFSE profile of wild-type andBax/, Bak/ CD4+ T cells as measured by flow cytometry 3 days after activation with soluble anti-CD3 (0.5 mg/ml).
Data are representative of three independent experiments.
(D) Surface expression of CD25 and CD69 on wild-type and Bax/, Bak/ CD4+ T cells one day after activation with anti-CD3 (solid line) or anti-CD3
plus anti-CD28 (broken line) as determined by flow cytometry. CD25 and CD69 surface staining of unstimulated cells is depicted by the gray histo-
gram. Data are representative of two independent experiments.
(E) T cell viability under conditions of cytokine withdrawal. Wild-type (filled bars) and Bax/, Bak/ (open bars) T cells were activated with anti-CD3
and anti-CD28 for 3 days, then washed and replated in fresh medium with no exogenous cytokines. Cell viability was measured by exclusion of
propidium iodide (PI) by flow cytometry. Data represent the mean ± SD for samples in triplicate from one of three independent experiments.
(F) T cell viability in response to apoptotic stimuli. Wild-type and Bax/, Bak/ T cells were activated as shown in (E) and then subjected to the
following various apoptotic stimuli: g radiation (500 rad), doxorubicin (2 mg/ml), or H2O2 (100 mM). ‘‘Untr’’ stands for untreated. Percent viable cells
was determined by PI exclusion and expressed as mean ± SD for triplicate cultures.viability was measured over time. As seen in Figure 1E,
wild-type T cells progressively lost viability in the absence
of cytokine stimulation, whereasBax/, Bak/ T cells re-
mained viable. ActivatedBax/, Bak/ T cells also main-
tained viability when challenged with various apoptotic
stimuli including g radiation, doxorubicin, and hydrogen
peroxide (Figure 1F). Thus, deficiency of Bax and Bak
confers T cell resistance to apoptosis despite a block in
antigen-specific proliferation.
Bax and Bak Control T Cell Responsiveness In Vivo
To address whether deficiency of Bax and Bak affects T
cell responsiveness in the context of a normal adaptive im-
mune response, we infected wild-type or Bax/, Bak/
chimeric animals with a recombinant variant of the270 Immunity 27, 268–280, August 2007 ª2007 Elsevier Inc.Gram-positive bacterium L. monocytogenes expressing
OVA (rLmOVA) (Foulds et al., 2002). Seven days after in-
fection with rLmOVA, spleens from infected wild-type or
Bax/, Bak/ animals were analyzed for the expansion
of H-2Kb-restricted OVA-specific CD8+ T cells. Expansion
of OVA-specific T cells was observed in control chimeric
mice but was severely impaired in Bax/, Bak/ chi-
meras (Figure 2A). This impairment was not due to slower
kinetics for CD8+ T cell expansion in Bax/, Bak/ mice
because Bax/, Bak/ mice failed to generate a signifi-
cant number of OVA-specific T cells over the course of
rLmOVA infection (Figure 2B). Moreover, loss of Bax and
Bak crippled effector-cytokine production by CD8+ and
CD4+ T cells in response to rLmOVA infection (Figure 2C
and data not shown). Collectively, these data suggest
Immunity
Bax and Bak Regulate Ca2+-Dependent T Cell ProliferationFigure 2. Impaired In Vivo T Cell Responses to L. monocyto-
genes Infection in Bax/, Bak/ Chimeric Mice
(A) Flow cytometry of splenocytes from wild-type or Bax/, Bak/
chimeric animals 7 days after i.v. infection with recombinant L. mono-
cytogenes expressing OVA (rLmOVA, 5e4 CFU). Numbers above gate
indicate the percentage of OVA-specific cells as determined by tetra-
mer staining on CD8+ cells. The bar graph indicates the total number of
KbOVA257-264-specific CD8
+ cells per wild-type (closed bar) or Bax/,
Bak/ (open bar) spleen. The data represent the mean ± SEM of three
animals per genotype and are representative of one of three indepen-
dent experiments.
(B) Percentage of OVA-specific CD8+ T cells in blood of wild-type
(closed symbols) or Bax/, Bak/ (open symbols) animals over time
after infection with rLmOVA as determined by tetramer staining and
flow cytometry. Each symbol represents one mouse.
(C) Cytokine production as assessed by intracellular staining (ICS) and
flow cytometry. Splenocytes from day 7 infected wild-type or Bax/,
Bak/ animals were restimulated with OVA257–264 or LLO190–201 pep-
tides (for CD8+ and CD4+ T cells, respectively) in the presence of Golgi-
Stop and examined for IFNg production by ICS and flow cytometry.
Numbers above gates indicate percentage of IFNg-producing cells
in spleen. Bar graphs indicate the total number of IFNg-producingthat Bax and Bak are required for T cell proliferation and




TCR engagement initiates an organized cascade of signal-
ing events that promote the transition of naive or memory
T cells to activated effector T cells. For investigating pos-
sible mechanisms underlying the T cell proliferation defect
observed in Bax/, Bak/ T cells, the activation of vari-
ous T cell signaling pathways in wild-type and Bax/,
Bak/ T cells was examined after TCR activation. TCR-
induced intracellular Ca2+ mobilization was dramatically
decreased after anti-CD3 crosslinking of Bax/, Bak/
CD4+ T cells relative to wild-type controls (Figure 3A), sug-
gesting a role for Bax and Bak in the control of TCR-regu-
lated Ca2+ homeostasis. No marked difference in other
TCR-triggered signaling events, including extracellular-
receptor-activated kinase (ERK) phosphorylation, NF-kB
activation, or tyrosine phosphorylation, were observed af-
ter anti-CD3 stimulation (Figure 3B, and data not shown).
Increased [Ca2+]i after TCR engagement is mediated by
the generation of IP3, which promotes Ca
2+ release from
the ER through activation of IP3R Ca
2+ channels (Lewis,
2001). Depletion of ER Ca2+ stores in turn promotes extra-
cellular Ca2+ entry through CRAC channels in the plasma
membrane, leading to a sustained increase in [Ca2+]i. TCR
engagement promotes IP3 generation by activating
PLCg1, an enzyme that converts membrane-associated
PIP2 to diacylglycerol (DAG) and IP3. Phosphorylation of
PLCg1 was induced in Bax/, Bak/ T cells after TCR
engagement (Figure 3C), suggesting the Ca2+-signaling
defect in Bax/, Bak/ T cells occurred downstream of
IP3 generation. To assess the responsiveness of wild-type
or Bax/, Bak/ T cells to IP3 directly, we measured
[Ca2+]i after treatment with a membrane-permeable IP3
ester (Chen et al., 2004). Elevation of [Ca2+]i by the IP3 es-
ter was decreased in Bax/, Bak/ T cells in relation to
controls, with fewer than 50% of Bax/, Bak/ T cells
responding after treatment (Figure 3D).
The observed decrease in TCR- and IP3-inducible Ca
2+
fluxes in Bax/, Bak/ T cells may be due to impaired
Ca2+ release from ER stores. For testing this possibility,
wild-type and Bax/, Bak/ T cells were stimulated by
anti-CD3 crosslinking in the absence of extracellular
Ca2+, and the increase in [Ca2+]i due to intracellular Ca
2+
release was measured by flow cytometry. TCR stimulation
induced an increase in [Ca2+]i in wild-type cells, and such
an increase was absent in Bax/, Bak/ cells, suggest-
ing a defect in TCR-induced Ca2+ release from intracellular
stores (Figure S4). Upon readdition of extracellular Ca2+,
wild-type cells displayed increased [Ca2+]i, suggesting
CD8+ and CD4+ T cells per spleen. The data represent the mean ±
SEM of three animals from one of three independent experiments.
Statistical significance was determined by paired Student’s t test
(*p < 0.05, **p < 0.01).Immunity 27, 268–280, August 2007 ª2007 Elsevier Inc. 271
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Bax and Bak Regulate Ca2+-Dependent T Cell ProliferationFigure 3. Impaired [Ca2+]i Signaling in Bax
/, Bak/ T Cells
(A) [Ca2+]i of wild-type or Bax
/, Bak/ T cells after TCR stimulation. CD4+ T cells were incubated with fluo-4 dye and anti-CD3 antibody, washed,
and plated on coverslips. Changes in [Ca2+]i were measured by fluorescence microscopy after anti-CD3 crosslinking (indicated by arrow) and ex-
pressed as a function of time. The inset shows representative fields depicting [Ca2+]i of wild-type or Bax
/, Bak/ T cells with (+) or without ()
anti-CD3 crosslinking.
(B and C) Immunoblot analysis of phosphorylated Erk (B) or PLCg1 (C) in lysates from wild-type or Bax/, Bak/ T cells stimulated for the indicated
times with anti-CD3 (10 mg/ml).
(D) [Ca2+]i of wild-type orBax
/, Bak/ T cells after stimulation with 10 mM IP3 ester. T cells were loaded with indo-1 dye and [Ca
2+]i measured by flow
cytometry.
(E and F) [Ca2+]i of wild-type or Bax
/, Bak/ T cells after thapsigargin (Tg) treatment. [Ca2+]i of CD4
+ T cells was measured after application of Tg in
Ca2+-free buffer containing 1 mM EGTA (E) and measured again after switching to 1.8 mM Ca2+ solution (F). The data represent mean ± SEM for at
least 90 cells from multiple trials.influx of extracellular Ca2+ through open CRAC channels.
This increase in [Ca2+]i was blunted in Bax
/, Bak/ T
cells, suggesting that Bax/, Bak/ T cells exhibited in-
complete activation of Ca2+ influx by TCR stimulation
alone. Together, the data suggest that Bax and Bak act
at the level of the ER to control release of intracellular
Ca2+ stores in response to TCR-mediated IP3 signals.
To assess ER Ca2+ content, we measured [Ca2+]i of
wild-type and Bax/, Bak/ T cells after treatment with
thapsigargin (Tg). Tg acts to deplete ER Ca2+ stores by
inhibiting the sarcoplasmic endoplasmic reticulum Ca2+
ATPase (SERCA) pump, which resequesters cytoplasmic
Ca2+ to the ER in an ATP-dependent fashion (Thastrup
et al., 1990). In the absence of extracellular Ca2+, the Tg-
stimulated increase in [Ca2+]i was reduced in Bax
/,
Bak/ T cells in relation to wild-type controls (Figure 3E
and Figure S5), suggesting a reduced ER Ca2+ content in272 Immunity 27, 268–280, August 2007 ª2007 Elsevier Inc.Bax/, Bak/ T cells. The decreased intracellular Ca2+
mobilization observed in Bax/, Bak/ T cells in re-
sponse to Tg was not due to increased Ca2+ efflux across
the plasma membrane because Tg-dependent ER Ca2+
release was also reduced in Bax/, Bak/ T cells treated
with lanthanum chloride to inhibit plasma membrane Ca2+
pumps (Figure S5). Ca2+ influx after Tg-induced ER store
depletion was similar between wild-type and Bax/,
Bak/ T cells (Figure 3F). Thus, Ca2+ influx in response
to ER store depletion was normal in the absence of Bax
and Bak. Collectively, these data demonstrate that defi-
ciency of Bax and Bak in T cells lowers ER Ca2+ content.
Reduced ER Ca2+ content and decreased IP3-dependent
Ca2+ release from the ER result in a reduced [Ca2+]i re-
sponse to TCR stimulation. Thus, the predominant defect
in Bax/, Bak/ T cells appears to be decreased IP3-de-
pendent Ca2+ release that is from intracellular stores and
Immunity
Bax and Bak Regulate Ca2+-Dependent T Cell ProliferationFigure 4. Bax/, Bak/ T Cells Display Changes in TCR-Induced [Ca2+]i Oscillations
(A) Representative traces of wild-type (black) and Bax/, Bak/ (red) T cells displaying [Ca2+]i oscillations after stimulation with anti-CD3. CD4
+ T
cells were loaded with fura-2 dye, plated onto anti-CD3 coated coverslips, and [Ca2+]i measured by epifluorescence microscopy. Time t = 0 represents
the point of contact between T cells and coverslips.
(B) A scatter plot showing the relationship between mean [Ca2+]i for the spikes observed during a 50 min observation period and spike frequency for
wild-type (black) or Bax/, Bak/ (red) T cells after activation with anti-CD3. Each data point represents the response of one cell.
(C) [Ca2+]i spike amplitude histograms for wild-type and Bax
/, Bak/ T cells after anti-CD3 stimulation.
(D) Average integrated [Ca2+]i responses for wild-type or Bax
/, Bak/ T cells after anti-CD3 stimulation. Data were calculated from traces of 96
wild-type and 87 Bax/, Bak/ T cells that responded to anti-CD3 with one or more [Ca2+]i spikes over 50 min. The data are representative of
four independent experiments.that results in insufficient store depletion to fully activate
CRAC channels in response to TCR ligation.
Bax and Bak Modulate TCR-Dependent Ca2+
Oscillations
The information conveyed by intracellular Ca2+ signals
depends on the frequency and amplitude of [Ca2+]i eleva-
tions. T cell receptor stimulation induces both transient
and oscillatory [Ca2+]i spikes (Donnadieu et al., 1992a;
Donnadieu et al., 1992b). To assess the effect of com-
bined deficiency of Bax and Bak on [Ca2+]i dynamics
within a single cell, we examined changes in [Ca2+]i over
time in individual T cells after TCR ligation. CD4+ cells from
wild-type or Bax/, Bak/ chimeric animals were loaded
with fura-2 dye and activated with anti-CD3-coated cover-
slips. [Ca2+]i signals were monitored over 50 min after
anti-CD3 stimulation. Figure 4A depicts representative
single-cell traces of [Ca2+]i oscillations in wild-type andBax/, Bak/ T cells after TCR ligation. Anti-CD3 stimu-
lation induced transient [Ca2+]i spikes in both wild-type
and Bax/, Bak/ T cells; however, Bax/, Bak/ T
cells displayed a higher frequency of [Ca2+]i spikes than
wild-type cells. Approximately 20% of respondingBax/,
Bak/ T cells displayed ten [Ca2+]i spikes or more,
whereas no wild-type cells responded with more than
eight spikes over the same time period (Figure 4B). In con-
trast, the amplitudes of the [Ca2+]i spikes induced by anti-
CD3 stimulation were lower in Bax/, Bak/ T cells rela-
tive to wild-type controls (Figure 4C). Consequently, the
integrated [Ca2+]i signal in response to TCR stimulation
for the population of cells analyzed was diminished in
Bax/, Bak/ T cells compared with wild-type cells,
with the maximal integrated [Ca2+]i response of Bax
/,
Bak/ T cells reaching only 30%–35% of that observed
for wild-type cells (Figure 4D). Together, these data sug-
gest that loss of Bax and Bak modifies the nature ofImmunity 27, 268–280, August 2007 ª2007 Elsevier Inc. 273
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the Ca2+ Mobilization Defect of Bax/,
Bak/ T Cells
(A) Transduction of Bax/, Bak/ T cells with
Bax retrovirus. CD4+ T cells fromBax/, Bak/
chimeric mice were transduced with empty
hCD8-Mig retrovirus (Vec) or retrovirus encod-
ing Bax. Cells were incubated with fluo-4 dye,
PE-tagged antibody against hCD8, and anti-
CD3, washed, and plated on coverslips. A rep-
resentative field of view from confocal imaging
is displayed.
(B) Western blot of Bax expression in wild-type
or Bax/, Bak/ CD4+ T cells transduced
with empty hCD8-Mig retrovirus (Vec) or retro-
virus encoding Bax.
(C) [Ca2+]i ofBax
/, Bak/ T cells re-express-
ing Bax. Changes in [Ca2+]i were measured
by confocal microscopy after anti-CD3 cross-
linking and expressed as a function of time.
The traces represent the [Ca2+]i for the popula-
tion of nontransduced (hCD8, black) and
transduced (hCD8+, red) cells within one field
of view.
(D) Quantitation of peak [Ca2+]i after anti-CD3
crosslinking for T cells in (C). The data repre-
sent the mean ± SEM for T cells from three
independent mice.
(E) Viability of Bax/, Bak/ T cells re-ex-
pressing Bax after cytokine withdrawal. Wild-
type (filled bars) andBax/, Bak/ (open bars)
T cells transduced with empty hCD8-Mig retro-
virus (Vec) or retrovirus encoding Bax were
cultured in medium containing no exogenous
cytokines. Cell viability was determined by try-
pan-blue exclusion 72 hr after cytokine with-
drawal for T cells from two independent
Bax/, Bak/ chimeric mice. The data repre-
sent the mean ± SD for samples in triplicate.
(F) Ionomycin rescues the proliferative defect
of Bax/, Bak/ T cells. Proliferation of wild-
type (closed bars) or Bax/, Bak/ (open bars) T cells stimulated with anti-CD3 or anti-CD3 and anti-CD28 (1 mg/ml) in the presence or absence of
ionomycin (250 ng/ml) is shown. Proliferation was measured 3 days after stimulation by 3[H]-thymidine incorporation and expressed as mean ± SD.
The data are representative of three independent experiments.TCR-stimulated [Ca2+]i signals: TCR stimulation triggers
higher-frequency but lower-amplitude [Ca2+]i oscillations
in Bax/, Bak/ T cells, leading to an overall reduction
in the integrated antigen-stimulated [Ca2+]i signal.
Re-expression of Bax Restores Ca2+ Signaling in
Bax/, Bak/ T Cells
One possible explanation for the unresponsiveness of
Bax/, Bak/ T cells is that lymphocyte development
has been altered as a result of the combined deficiency
of Bax and Bak, leading to the selection of mature T cells
with an altered threshold for Ca2+ signaling. Although re-
sistance to apoptosis in Bax/, Bak/ thymocytes leads
to alterations in thymic cellularity in vivo (Rathmell et al.,
2002), no substantial difference in the Vb repertoire of
peripheral T cells from wild-type or Bax/, Bak/ chime-
ric animals was observed (Figure S2). To address whether
the defect in [Ca2+]i signaling was due to a cell-intrinsic
requirement for Bax or Bak, we assessed TCR-induced274 Immunity 27, 268–280, August 2007 ª2007 Elsevier Inc.[Ca2+]i signaling in Bax
/, Bak/ T cells after reintroduc-
tion of Bax. Bax/, Bak/ T cells were transduced with
control retrovirus (hCD8-Mig) or retrovirus encoding cDNA
for mouse Bax. The hCD8-Mig retrovirus drives the coex-
pression of a cDNA of interest and a functionally inert
human CD8 biomarker, which permitted the identification
of transduced T cells within the population (Figure 5A).
Bax/, Bak/ T cells transduced with Bax retrovirus ex-
pressed Bax protein to a similar degree as that observed
in wild-type T cells (Figure 5B). The effect of Bax re-
expression on [Ca2+]i signaling in Bax
/, Bak/ T cells
was measured after TCR stimulation by confocal micros-
copy. TCR-induced [Ca2+]i mobilization was restored in
Bax/, Bak/ T cells re-expressing Bax, whereas
Bax/, Bak/ T cells transduced with the control vector
remained unresponsive (Figures 5C and 5D). Importantly,
hCD8-negative cells from Bax-transduced cultures con-
tinued to display defective [Ca2+]i mobilization, indicating
that the defect in TCR-dependent [Ca2+]i signaling in
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of Bax.
To assess whether introduction of Bax could affect
the sensitivity of Bax/, Bak/ T cells to apoptosis, we
transduced Bax/, Bak/ T cells with control or Bax-
expressing retrovirus and measured the viability of trans-
duced cells (hCD8+) cultured in the absence of exogenous
cytokines. As seen in Figure 5E, Bax/, Bak/ T cells ex-
pressing Bax displayed decreased viability in response to
cytokine withdrawal, whereas Bax/, Bak/ T cells
transduced with control vector remained viable. Bax/,
Bak/ T cells expressing Bax also displayed decreased
viability when treated with g-radiation or doxorubicin
(data not shown).
Ionomycin Corrects the Proliferative Defect
Exhibited by Bax/, Bak/ T Cells
We next examined whether the impaired proliferative re-
sponse ofBax/, Bak/ T cells could be solely attributed
to the underlying defect in Ca2+ signaling. To address this
issue, we examined the ability of the Ca2+ ionophore ion-
omycin to restore the proliferative response of Bax/,
Bak/ T cells. Wild-type and Bax/, Bak/ T cells
were stimulated with anti-CD3 alone or in concert with
anti-CD28 in the presence or absence of ionomycin, and
proliferation was measured after 48 hr of culture by 3[H]-
thymidine incorporation. TCR ligation in the presence of
ionomycin resulted in equivalent levels of proliferation of
Bax/, Bak/ T cells in comparison to wild-type T cells
(Figure 5F). Costimulation through CD28 augmented the
proliferative response of both populations to an equivalent
extent when ionomycin was present.
Bax- and Bak-Dependent Ca2+ Flux Stimulates
Mitochondrial Bioenergetics
Ca2+ release from the ER can enhance mitochondrial bio-
energetics by stimulating enzymes of the tricarboxylic
acid (TCA) cycle to generate ATP and other metabolic
intermediates (Krauss et al., 2001). One consequence of
Ca2+-dependent stimulation of TCA cycle dehydroge-
nases is an elevation of mitochondrial NADH. NADH acts
as an electron donor during mitochondrial respiration;
electrons are transferred from NADH to complex I of the
mitochondrial electron transport chain, a key step in ATP
generation by mitochondria. To assess whether mito-
chondrial bioenergetics could be stimulated by T cell acti-
vation, we measured mitochondrial NAD(P)H fluores-
cence in CD4+ T cells after anti-CD3 crosslinking. TCR
triggering promoted a rapid increase in NAD(P)H fluores-
cence in wild-type T cells (Figures 6A and 6B). Most of
the NAD(P)H in response to TCR stimulation was gener-
ated through TCA-cycle production of NADH because
the signal almost completely returned to baseline after ad-
dition of the mitochondrial electron transport uncoupling
agent FCCP (Figure 6A). TCR-induced NADH accumula-
tion was reduced in Bax/, Bak/ T cells, and the max-
imal NADH elevation approached only 30%–40% of con-
trols (Figure 6B). To test whether Ca2+ signals could affect
this response, we measured NAD(P)H fluorescence of WTand Bax/, Bak/ T cells after ionomycin treatment. As
seen in Figure 6C, ionomycin stimulated similar increases
in NAD(P)H fluorescence in both wild-type and Bax/,
Bak/ T cells. This Ca2+-dependent NAD(P)H production
was also due to increased mitochondrial NADH because
FCCP completely collapsed the response.
Figure 6. Bax/, Bak/ T Cells Are Defective for TCR-
Dependent Mitochondrial NADH Production
(A) NAD(P)H fluorescence of wild-type (black) or Bax/, Bak/ (red) T
cells over time after anti-CD3 crosslinking. The mitochondrial uncou-
pling agent FCCP (1 mg/ml) was added as indicated.
(B) Mitochondrial NAD(P)H fluorescence before () or after (+) anti-
CD3 crosslinking. Data are expressed as fold increase over FCCP-
treated T cells and expressed as mean ± SD for triplicate samples.
(C) NAD(P)H fluorescence of wild-type (black) orBax/, Bak/ (red) T
cells over time after treatment with ionomycin (250 ng/ml). FCCP was
added as indicated.Immunity 27, 268–280, August 2007 ª2007 Elsevier Inc. 275
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Bax and Bak Regulate Ca2+-Dependent T Cell ProliferationFigure 7. TCR-Induced ROS Generation Is Impaired in Bax/, Bak/ T Cells
(A) Oxidation of the ROS-sensitive dye DCF-DA in wild-type or Bax/, Bak/ T cells after anti-CD3 crosslinking. Top panels display representative
fields of view for cells undergoing DCF oxidation (green) before () and after (+) anti-CD3 crosslinking. The phase-contrast view for the same field is
shown.
(B) Quantification of DCF oxidation for wild-type (black) or Bax/, Bak/ (red) T cells after anti-CD3 treatment as in (A). ROS production by T cells
was measured after anti-CD3 crosslinking alone or in combination with ionomycin (250 ng/ml). The data represent the mean ROS intensity ± SD in
arbitrary units (a.u.) for triplicate samples and are representative of three independent experiments.
(C) Bax re-expression restores TCR-induced ROS production by Bax/, Bak/ T cells. Quantification of DCF dye oxidation after anti-CD3 cross-
linking in wild-type (black) or Bax/, Bak/ (red) T cells transduced with empty vector (Vec) or Bax. The data are representative of two independent
experiments.
(D) Proliferation of T cells in the presence of inhibitors of ROS production. Purified T cells from wild-type animals were left unstimulated (open bars) or
stimulated with anti-CD3 and anti-CD28 (closed bars) in the presence of increasing concentrations of DPI, BHA, Ebselen, or NAC. Proliferation was
measured by 3[H]-thymidine incorporation 48 hr after activation. The data represent the mean ± SD for triplicate samples and are representative of
three independent experiments.
(E) Proliferation of wild-type (black) or Bax/, Bak/ (white) T cells stimulated with anti-CD3 or anti-CD3 plus ionomycin in the presence or absence
of DPI (100 nM). Data are expressed as mean ± SD for triplicate samples and are representative of two independent experiments.Bax and Bak Are Required for TCR-Dependent
ROS Production
One predicted consequence of increased mitochondrial
NADH levels is the generation of cellular ROS from a satu-
rated electron transport chain. ROS are produced in T
cells in response to TCR stimulation, a process that de-
pends on TCR-mediated Ca2+ signaling (Devadas et al.,
2002). To determine whether TCR-induced ROS produc-
tion is influenced by Bax and Bak, we stimulated wild-
type and Bax/, Bak/ T cells by anti-CD3 crosslinking
in the presence of the redox-sensitive dye DCF-DA and
measured dye oxidation by confocal microscopy. TCR
stimulation rapidly induced ROS production in wild-type
T cells but not Bax/, Bak/ T cells (Figure 7A). Approx-
imately 80% of wild-type T cells responded to TCR stimu-
lation with maximal DCF fluorescence, compared to 5% of276 Immunity 27, 268–280, August 2007 ª2007 Elsevier Inc.Bax/, Bak/ T cells. However, Bax/, Bak/ T cells
displayed a normal ROS response after addition of iono-
mycin (Figure 7B), suggesting that Ca2+ signals could res-
cue the defect in ROS production observed in Bax/,
Bak/ T cells. Consistent with this possibility, re-expres-
sion of Bax restored TCR-induced ROS production in
Bax/, Bak/ T cells, indicating a cell-intrinsic require-
ment for Bax in this process (Figure 7C).
To assess the impact of ROS production on T cell pro-
liferation, we measured the proliferative responses of
wild-type T cells cultured in the presence of several com-
pounds known to inhibit the generation of TCR-dependent
ROS: diphenylene iodonium (DPI), butylated hydroxyani-
sole (BHA), Ebselen, and N-acetyl-cysteine (NAC). Each
compound induced a dose-dependent decrease in T cell
proliferation (Figure 7D). To assess whether enhanced
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cell proliferation, we activated wild-type and Bax/,
Bak/ T cells by anti-CD3 and ionomycin stimulation in
the presence of DPI. DPI is an inhibitor of flavoprotein
dehydrogenases reported to block TCR-induced produc-
tion of H2O2 and superoxide (Jackson et al., 2004). DPI in-
hibited the proliferation of wild-type and Bax/, Bak/ T
cells, even in the presence of ionomycin (Figure 7E), sug-
gesting that the ROS-dependent signal that drives prolif-
eration lies downstream of TCR-mediated effects on
[Ca2+]i. Together, these data demonstrate that Bax and
Bak contribute to the ability of TCR- and Ca2+-dependent
signaling to induce cellular ROS and subsequent T cell
proliferation.
DISCUSSION
The proapoptotic Bcl-2 family members Bax and Bak are
required regulators of mitochondrial-dependent apoptotic
pathways in lymphocytes. Here, we demonstrate a nona-
poptotic role for Bax and Bak in the control of T cell prolif-
eration. Bax/, Bak/ T cells display defective prolifera-
tion in response to TCR and costimulatory signals in vitro
and fail to proliferate or produce effector cytokines in
response to the bacterial pathogen L. monocytogenes
in vivo. TCR-dependent Ca2+ signaling is impaired in
Bax/, Bak/ T cells because of reduced ER Ca2+ re-
lease after TCR ligation. In comparison to wild-type cells,
Bax/, Bak/ T cells displayed [Ca2+]i oscillations that
had higher frequency but lower amplitudes after TCR
stimulation that resulted in a reduced TCR-induced rise
in [Ca2+]i. Re-expression of Bax in Bax
/, Bak/ T cells
restored TCR-dependent Ca2+ signaling, indicating that
the defect in Ca2+ signaling is due to the cell-intrinsic ab-
sence of Bax in mature T cells. The decreased Ca2+ signal-
ing is sufficient to account for the hypoproliferative pheno-
type of T cells lacking both Bax and Bak because
restoration of Ca2+ signals with a Ca2+ ionophore restored
their ability to proliferate. TCR-dependent [Ca2+]i signals
promoted a rapid increase in mitochondrial NADH pro-
duction and ROS generation, and the normal coupling of
these events is mediated by Bax and Bak. Together, the
results establish Bax and Bak as critical regulators of not
only T cell apoptosis but also T cell proliferation and dem-
onstrate that Bax and Bak affect T cell activation through
control of TCR-dependent Ca2+ mobilization and mito-
chondrial bioenergetics.
The present studies, combined with other lines of evi-
dence, indicate that modulators of T cell apoptosis can
also function to limit T cell responsiveness, suggesting
that the regulation of proliferation and apoptosis are intrin-
sically linked in lymphocytes. Mice defective for Fas sig-
naling, which triggers apoptosis of activated T cells, also
display defects in T cell proliferation (Scholz et al., 1988;
Walsh et al., 1998; Salmena et al., 2003; Chau et al.,
2005). Transgenic overexpression of Bcl-2 or Bcl-XL con-
fers apoptotic resistance to T cells but delays cell-cycle
entry after TCR stimulation (Linette et al., 1996; Mazel
et al., 1996; Li et al., 2002). The present data demonstratethat the proliferative defect observed in those studies is
not simply a consequence of overexpression of Bcl-2 or
Bcl-XL. Loss of Bax and Bak ablates susceptibility to apo-
ptosis and also increases the threshold for T cell activation
in vitro and in vivo. As with their effects on T cell viability,
Bax and Bak displayed redundant effects on T cell activa-
tion, with only their combined loss leading to defects in
proliferation. Our data suggest that Bax and Bak function
through at least two mechanisms to prevent abnormal
lymphocyte expansion: Bax and Bak control the viability
of naive and activated T cells through the initiation of mito-
chondrial-dependent apoptosis, but they also function to
prevent unchecked T cell proliferation by modulating ER
Ca2+ release.
A growing body of evidence suggests that Bcl-2-family
proteins, in addition to their role in mitochondrial physiol-
ogy, can influence cellular Ca2+ dynamics through their
localization to and action at the ER. Bcl-2 and Bcl-XL
physically associate with the IP3R and alter its ability to re-
lease Ca2+ from the ER (Chen et al., 2004; White et al.,
2005). Conversely, Bax and Bak can regulate ER Ca2+ dy-
namics (Scorrano et al., 2003; Zong et al., 2003). Here, we
demonstrate that defective TCR-dependent Ca2+ signal-
ing underlies the T cell proliferation defect of Bax/,
Bak/ T cells. The integrated TCR- and IP3-dependent
Ca2+ signal is reduced in Bax/, Bak/ T cells because
of reduced Ca2+ release from the ER, as well as reduced
Ca2+ influx from outside the cell. However, store-deple-
tion-induced Ca2+ influx appears to be normal in Bax/,
Bak/ T cells because the intracellular-dependent
[Ca2+]i signal after thapsigargin treatment was normal. To-
gether, these data suggest that although ER Ca2+ content
is reduced in Bax/, Bak/ T cells, insufficient depletion
of ER Ca2+ stores due to low-amplitude [Ca2+]i spiking in
Bax/, Bak/ T cells may cause reduced influx of Ca2+
through the plasma membrane.
The frequency and amplitude of [Ca2+]i oscillations dic-
tates the signaling properties of Ca2+ and promotes differ-
ent biological outcomes (Berridge et al., 2000). The pres-
ent results demonstrate that loss of Bax and Bak alters
both the magnitude and nature of [Ca2+]i signals triggered
by TCR stimulation. Multiple lines of evidence suggest that
proteins of the Bcl-2 family modify Ca2+ signaling by alter-
ing [Ca2+]i oscillations. The overexpression of antiapop-
totic members of the Bcl-2 family can promote ligand-
induced, IP3R-dependent [Ca
2+]i oscillations (White
et al., 2005; Zhong et al., 2006). Mechanistically, the bind-
ing of Bcl-XL to the IP3R increases its sensitivity to small
amounts of IP3, resulting in greater frequency of ER Ca
2+
release by receptor stimulation; however, Bcl-XL also ren-
ders the IP3R more sensitive to inhibition by high Ca
2+
(White et al., 2005). The consequence is increased fre-
quency of [Ca2+]i oscillations that have lower amplitudes,
resulting in an overall decrease in the integrated [Ca2+]i
response. In Bax/, Bak/ T cells, where the activity of
Bcl-2 or Bcl-XL is not opposed by Bax or Bak, we ob-
served a greater frequency of TCR-induced [Ca2+]i spikes
with lower amplitude. The consequence of this change
in [Ca2+]i oscillations is an overall reduction of theImmunity 27, 268–280, August 2007 ª2007 Elsevier Inc. 277
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2+-de-
pendent events such as NADH production and ROS gen-
eration.
TCR ligation activates pathways of cellular metabolism
for energy production to meet the increased bioenergetic
demands of cell growth and proliferation (Krauss et al.,
2001; Frauwirth et al., 2002). How does the shuttling of
Ca2+ between the ER and mitochondria augment T cell ac-
tivation and mitochondrial bioenergetics? Ca2+ released
from the ER is rapidly taken up by mitochondria located
in close proximity (Rizzuto et al., 1993). Periodic release
of Ca2+ from the ER stimulates mitochondrial enzymes
of the TCA cycle, leading to the maintenance of efficient
oxidative phosphorylation and ATP production (Haj-
noczky et al., 1995; Duchen, 2000). However, in response
to TCR stimulation, mitochondrial-dependent NADH pro-
duction doubles. Thus, the Ca2+-induced increase in mito-
chondrial NADH is greater than that needed to sustain the
mitochondrial respiratory chain. The electron transport
chain is limited by the electrochemical potential being
generated by the increased NADH available as shown
by the ability of the electron transport chain to reduce
mitochondrial NADH accumulation when an uncoupling
agent (such as FCCP) is given. Enhanced NADH produc-
tion stimulated by TCR-dependent [Ca2+]i signals results
in increased mitochondrial-dependent ROS production,
a process that is blunted inBax/, Bak/ T cells because
of a reduced overall [Ca2+]i signal.
What is the importance of Ca2+-dependent ROS gener-
ation for T cell activation? Experiments conducted with
ROS scavengers have suggested that ROS may be re-
quired for T cell proliferation (Chaudhri et al., 1986). TCR-
dependent ROS generation can affect mitogen-activated
protein kinase (MAPK) activation and early cytokine pro-
duction in T cells (Devadas et al., 2002; Jackson et al.,
2004). Our data suggest that ROS generation is critical
for the initiation of cell division after TCR stimulation and
that TCR-stimulated ROS is dependent on Ca2+ signals
regulated by Bax and Bak. Further experiments must be
performed to identify the sources and downstream targets
of TCR-dependent ROS generation. It should be noted
that although T cells lacking functional NADPH oxidase
(Ncf1/ and Cybb/, respectively) display reduced
TCR-dependent ROS generation, DPI promotes a further
reduction of ROS levels, suggesting that TCR-dependent
ROS is generated by additional sources (Jackson et al.,
2004). Our results suggest that Ca2+-dependent mito-
chondrial NADH production may contribute to this pro-
cess by driving increased rates of mitochondrial respira-
tion. ROS is a natural byproduct of mitochondrial
respiration when electrons (via NADH) are transferred to
O2 during aerobic ATP generation. In this fashion, mito-
chondrial-derived ROS may function as a metabolic signal
that signifies sufficient energetic conditions exist to sup-
port T cell proliferation.
Together, the present data establish that Bax and Bak
function as critical regulators of T cell-mediated immunity
by integrating diverse signals that regulate T cell prolifera-
tion, function, and survival. Bax and Bak function at the ER278 Immunity 27, 268–280, August 2007 ª2007 Elsevier Inc.to maintain sufficient ER Ca2+ stores to support TCR-de-
pendent Ca2+ signaling pathways. One way Bax and
Bak-dependent Ca2+ signaling may support T cell prolifer-
ation is through rapid effects on mitochondrial energy
(NADH) production and ROS generation. Loss of Bax
and Bak effectively renders the T cell population inert—T
cells are unable to respond to antigenic stimulation but
are also unable to die by apoptosis. Consistent with this
dual role, the T cell accumulation observed in Bax/,
Bak/ animals is entirely composed of small, inert popu-
lations of cells (Lindsten et al., 2000). Thus, through their
dual effects on proliferation and apoptosis, Bax and Bak
control the threshold required for antigen-specific T cell
activation and the homeostatic mechanisms that maintain
mature T cell viability in vivo.
EXPERIMENTAL PROCEDURES
Mice
Bax/, Bak/ animals have been described previously (Lindsten
et al., 2000). Wild-type or Bax/, Bak/ chimeric animals were gen-
erated through adoptive transfer of Bax+/+, Bak+/+ or Bax/, Bak/
bone marrow or E14-16 fetal liver into lethally irradiated Rag1-deficient
mice. Rag1-deficient and C57BL/6 mice were obtained from the
Jackson Laboratory (Bar Harbor, MA). All mice were maintained and
handled at the University of Pennsylvania according to institutional
guidelines.
T Cell Purification
Total or CD4+ T cells were isolated from the spleen and lymph nodes of
wild-type or Bax/, Bak/ chimeric animals 8–12 weeks after re-
constitution with positive or negative selection kits (StemCell Technol-
ogies, Vancouver, B.C.; Miltenyi Biotec Inc., Auburn, CA) and an
AutoMACS cell sorter. T cells were maintained in Iscove’s modified
Dulbecco’s medium (IMDM) supplemented with 10% fetal-bovine
serum, L-glutamine, b-mercaptoethanol, and antibiotics.
T Cell Stimulation and Apoptosis Assays
Purified T cells (0.5 to 1 3 106 cells/ml) were stimulated with plate-
bound anti-CD3 alone (0.1–10 mg/ml) or in combination with anti-CD28
(1 mg/ml) or ionomycin (250 ng/ml). Alternatively, total splenocytes
were activated with soluble anti-CD3 (0.1–1 mg/ml). T cell proliferation
was measured by 3[H]-thymidine incorporation (1 mCi/ml) 48 hr after
activation or by CFSE dye dilution. T cell ROS production was blocked
with diphenylene iodonium (DPI) at 10–100 nM. DPI, BHA, Ebselen,
and NAC were obtained from Sigma (St. Louis, MO). For apoptosis
assays, T cells were activated for 2 days with plate-bound anti-CD3
and anti-CD28 (5 mg/ml each), washed, and plated in the presence
of various apoptotic stimuli (13 106 cells/ml). For cytokine-withdrawal
experiments, T cells were cultured in the presence or absence of
recombinant IL-2 (50 U/ml, Peprotech). Viability was measured by pro-
pidium iodide (PI) exclusion by flow cytometry.
For Listeria infections, mice were immunized i.v. with a sublethal
dose of 5 3 104 CFU of recombinant LM expressing OVA (rLmOVA).
The construction of this strain has been described previously (Shen
et al., 1995; Foulds et al., 2002). Seven days after infection, spleno-
cytes were harvested and OVA-specific T cells detected with MHC
class I tetramers (KbOVA257-264). Alternatively, OVA-specific T cells in
the peripheral blood of infected mice were detected over time. For
intracellular staining, splenocytes were stimulated for 5 hr in IMDM
supplemented with 50 U/ml recombinant human IL-2, 1.0 ml/ml Golgi-
Stop (BD PharMingen, San Diego, CA), and the presence or absence of
OVA257–264 or listeriolysin O190–201 (LLO190–201) peptide. Intracellular
staining was performed with an intracellular staining kit and conju-
gated antibodies against IFN-g (clone XMG1.2) (BD PharMingen).
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Retroviral Transduction
Retrovirus forBax/, Bak/T cell transduction was produced with es-
tablished methods (Izon et al., 2001). In brief, 293T cells were cotrans-
fected with pCL-Eco retrovirus packaging vector and either empty
hCD8-Mig vector or hCD8-Mig encoding Bax cDNA, and culture super-
natant containing high-titer retrovirus was collected 48 hr after trans-
fection. CD4+ Bax/, Bak/ T cells were purified from spleen and
lymph nodes and activated for 24 hr with plate-bound anti-CD3 (5
mg/ml) and anti-CD28 (2.5 mg/ml). Activated T cells were cultured in 1
ml retroviral supernatant containing 8 mg/ml polybrene and centrifuged
at 2500 rpm for 90 min. Infected T cells were expanded for 3 days in the
presence of recombinant IL2 (50–200 U/ml). Transduced T cells were
identified with PE- or APC-conjugated antibodies against human
CD8a (clone RPA-T8, eBioscience). For some experiments, trans-
duced cells were purified by positive selection with anti-hCD8 microbe-
ads and magnetic sorting (Miltenyi Biotec).
Biochemistry
Purified T cells (2 3 106 cells/ml) were stimulated with plate-bound
anti-CD3 alone (1 mg/ml) or in combination with anti-CD28 (5 mg/ml)
or ionomycin (250 ng/ml). Alternatively, T cells were preincubated
with anti-CD3 (10 mg/ml) at 4C for 30 min and washed twice, and T
cell activation was induced at 37C by addition of anti-hamster-IgG
(5 mg/ml, Pearce) to crosslink cell-bound anti-CD3. T cells were lysed
with RIPA buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA,
1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS) containing
PMSF (1 mM), benzamidine (1 mM), Complete protease inhibitors
(Roche), and phosphatase inhibitor cocktail (Sigma). Protein lysates
were separated on a 10% SDS-PAGE gel, transferred to nitrocellulose,
and probed with antibodies against ERK (total and pT202/Y204),
PLCg1 (total and pY783) (Cell Signaling Technologies), and Bax (N-20,
Santa Cruz Biotechnology). Western blots were resolved with en-
hanced chemiluminescence (Amersham).
Calcium Measurements
For measurements of [Ca2+]i dynamics by flow cytometry, T cells were
incubated with anti-CD3 (10 mg/ml), probenicid (4 mM), and indo-1 (2
mg/ml) in RPMI containing 1% FCS for 30 min at 30C, washed, and
resuspended in serum-free RPMI. T cell [Ca2+]i signals were induced
by addition of anti-hamster-IgG or addition of IP3 ester (10 mM) and
measured with an LSR flow cytometer (Becton Dickinson). Thapsigar-
gin (Sigma) was added to cells at 1 mM in the presence or absence of
0.5 mM LaCl3 to block Ca
2+ extrusion across the plasma membrane.
For [Ca2+]i imaging by fluorescence or confocal microscopy, T cells
were preincubated with anti-CD3 and loaded with fluo-4, and then
they were seeded on coverslips coated with CellTac adhesive (Becton
Dickinson). [Ca2+]i signals were induced by addition of crosslinker. For
the study of single-cell [Ca2+]i dynamics, T cells were loaded with fura-
2 and applied to coverslips coated with anti-CD3. Fura-2 was alter-
nately excited at 340 and 380 nm, and the emitted fluorescence filtered
at 510 nm was collected and recorded with a CCD-based imaging
system running Ultraview software (Perkin Elmer).
NAD(P)H and ROS Measurements
Wild-type or Bax/, Bak/ T cells were preincubated with anti-CD3
(10 mg/ml) for 30 min, washed, and resuspended in Hanks’ balanced
salt solution (4 3 106 cells/ml). T cell activation was induced by addi-
tion of anti-hamster-IgG as described above. Autofluorescence of
NAD(P)H was monitored at 350/460 nm (excitation/emission) with a
multiwavelength excitation, dual-wavelength emission fluorimeter
(Delta RAM, PTI, Birmingham, NJ). ROS measurements were per-
formed as described previously (Madesh et al., 2005). In brief, 20,70-di-
chlorofluorescein diacetate (DCF-DA) was added during the last 15
min of preincubation; this was followed by crosslinking with anti-IgG.ROS production was determined by DCF dye oxidation as measured
by fluorescence microscopy.
Supplemental Data
Five figures are available at http://www.immunity.com/cgi/content/
full/27/2/268/DC1/.
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